0000899243-22-028991.txt : 20220817
0000899243-22-028991.hdr.sgml : 20220817
20220817162149
ACCESSION NUMBER: 0000899243-22-028991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220815
FILED AS OF DATE: 20220817
DATE AS OF CHANGE: 20220817
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trager James
CENTRAL INDEX KEY: 0001816549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 221174343
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-582-4923
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-15
0
0001787400
Nkarta, Inc.
NKTX
0001816549
Trager James
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2022-08-15
4
M
0
5000
3.89
A
67172
D
Common Stock
2022-08-15
4
S
0
5000
17.5311
D
62172
D
Stock Option (right to buy)
3.89
2022-08-15
4
M
0
5000
0.00
D
2029-09-05
Common Stock
5000
88243
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person at least 30 days prior to the trade date.
This transaction was executed in multiple trades at prices ranging from $17.50 to $17.62. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
The options exercised were fully vested. Unvested options will vest and become exercisable ratably in monthly installments until fully vested on September 5, 2023.
/s/ Alicia Hager, as Attorney-in-Fact
2022-08-17